Efficacy and Safety of Secukinumab in the Treatment of Chronic Plaque Psoriasis: A 52-Weeks Follow up Study. J Pak Assoc Dermatol 2024, 34 (1), 191-199. https://doi.org/10.66344/jpad.v34i1.2545.